These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


142 related items for PubMed ID: 9300609

  • 41. Mediation of the discriminative stimulus properties of 8-hydroxy-2-(di-n-propylamino) tetralin (8-OH-DPAT) by the putative 5-HT1A receptor.
    Tricklebank MD, Neill J, Kidd EJ, Fozard JR.
    Eur J Pharmacol; 1987 Jan 06; 133(1):47-56. PubMed ID: 2881789
    [Abstract] [Full Text] [Related]

  • 42. Behavioural effects of 7-OH-DPAT are solely due to stimulation of dopamine D2 receptors in the shell of the nucleus accumbens; turning behaviour.
    Koshikawa N, Kitamura M, Kobayashi M, Cools AR.
    Eur J Pharmacol; 1996 Jul 25; 308(3):235-41. PubMed ID: 8858293
    [Abstract] [Full Text] [Related]

  • 43. Double dissociation of the behavioural effects of R(+) 7-OH-DPAT infusions in the central and basolateral amygdala nuclei upon Pavlovian and instrumental conditioned appetitive behaviours.
    Hitchcott PK, Phillips GD.
    Psychopharmacology (Berl); 1998 Dec 25; 140(4):458-69. PubMed ID: 9888622
    [Abstract] [Full Text] [Related]

  • 44. Discriminative stimulus properties of S32504, a novel D3/D2 receptor agonist and antiparkinson agent, in rats: attenuation by the antipsychotics, aripiprazole, bifeprunox, N-desmethylclozapine, and by selective antagonists at dopamine D2 but not D3 receptors.
    Millan MJ, Iob L, Péglion JL, Dekeyne A.
    Psychopharmacology (Berl); 2007 Apr 25; 191(3):767-82. PubMed ID: 17047933
    [Abstract] [Full Text] [Related]

  • 45. Dopamine D3 receptor-preferring agonists increase dendrite arborization of mesencephalic dopaminergic neurons via extracellular signal-regulated kinase phosphorylation.
    Collo G, Zanetti S, Missale C, Spano P.
    Eur J Neurosci; 2008 Oct 25; 28(7):1231-40. PubMed ID: 18973551
    [Abstract] [Full Text] [Related]

  • 46. WAY 100635 produces discriminative stimulus effects in rats mediated by dopamine D(4) receptor activation.
    Marona-Lewicka D, Nichols DE.
    Behav Pharmacol; 2009 Feb 25; 20(1):114-8. PubMed ID: 19179855
    [Abstract] [Full Text] [Related]

  • 47. Characterization of the discriminative stimulus produced by the dopamine antagonist tiapride.
    Cohen C, Sanger DJ, Perrault G.
    J Pharmacol Exp Ther; 1997 Nov 25; 283(2):566-73. PubMed ID: 9353371
    [Abstract] [Full Text] [Related]

  • 48. The putative dopamine D3 agonist, 7-OH-DPAT, reduces dopamine release in the nucleus accumbens and electrical self-stimulation to the ventral tegmentum.
    Gilbert DB, Millar J, Cooper SJ.
    Brain Res; 1995 May 29; 681(1-2):1-7. PubMed ID: 7552265
    [Abstract] [Full Text] [Related]

  • 49. Antagonism of the discriminative stimulus effects of cocaine at two training doses by dopamine D2-like receptor antagonists.
    Costanza RM, Barber DJ, Terry P.
    Psychopharmacology (Berl); 2001 Nov 29; 158(2):146-53. PubMed ID: 11702088
    [Abstract] [Full Text] [Related]

  • 50. The putative dopamine D3 receptor agonist 7-OH-DPAT: lack of mesolimbic selectivity.
    Liu JC, Cox RF, Greif GJ, Freedman JE, Waszczak BL.
    Eur J Pharmacol; 1994 Nov 03; 264(3):269-78. PubMed ID: 7698165
    [Abstract] [Full Text] [Related]

  • 51. Effects of selective serotonin and dopamine agonists on plasma levels of glucose, insulin and glucagon in the rat.
    Uvnäs-Moberg K, Ahlenius S, Alster P, Hillegaart V.
    Neuroendocrinology; 1996 Mar 03; 63(3):269-74. PubMed ID: 8677015
    [Abstract] [Full Text] [Related]

  • 52. (-)-Nornicotine partially substitutes for (+)-amphetamine in a drug discrimination paradigm in rats.
    Bardo MT, Bevins RA, Klebaur JE, Crooks PA, Dwoskin LP.
    Pharmacol Biochem Behav; 1997 Dec 03; 58(4):1083-7. PubMed ID: 9408217
    [Abstract] [Full Text] [Related]

  • 53. D2 and D1 dopaminergic activity of 7-OH-DPAT.
    Sethy VH, Ellerbrock BR, Fici GJ, Wu H.
    Brain Res; 1996 Sep 09; 733(1):41-5. PubMed ID: 8891246
    [Abstract] [Full Text] [Related]

  • 54. Modulation of the discriminative stimulus effects of mu opioid agonists in rats: II. Effects of dopamine D2/3 agonists.
    Cook CD, Beardsley PM.
    Behav Pharmacol; 2004 Feb 09; 15(1):75-83. PubMed ID: 15075629
    [Abstract] [Full Text] [Related]

  • 55. The D3-receptor agonist (+/-)-7-hydroxy-N,N-di-n-propyl-2-aminotetralin (7-OH-DPAT) attenuates morphine-induced hyperlocomotion in mice.
    Suzuki T, Maeda J, Funada M, Misawa M.
    Neurosci Lett; 1995 Feb 24; 187(1):45-8. PubMed ID: 7617299
    [Abstract] [Full Text] [Related]

  • 56. Effects of dopamine D(2)-like receptor agonists in mice trained to discriminate cocaine from saline: influence of feeding condition.
    Collins GT, Jackson JA, Koek W, France CP.
    Eur J Pharmacol; 2014 Apr 15; 729():123-31. PubMed ID: 24561049
    [Abstract] [Full Text] [Related]

  • 57. Discriminative stimulus properties of flesinoxan.
    Ybema CE, Slangen JL, Olivier B, Mos J.
    Pharmacol Biochem Behav; 1990 Apr 15; 35(4):781-4. PubMed ID: 2140607
    [Abstract] [Full Text] [Related]

  • 58. Assessment of cocaine-like discriminative stimulus effects of dopamine D3 receptor ligands.
    Acri JB, Carter SR, Alling K, Geter-Douglass B, Dijkstra D, Wikström H, Katz JL, Witkin JM.
    Eur J Pharmacol; 1995 Aug 04; 281(2):R7-9. PubMed ID: 7589197
    [Abstract] [Full Text] [Related]

  • 59. In vivo occupancy of D2 dopamine receptors by 7-OH-DPAT.
    Levant B, Bancroft GN, Selkirk CM.
    Synapse; 1996 Sep 04; 24(1):60-4. PubMed ID: 9046077
    [Abstract] [Full Text] [Related]

  • 60. Repeated imipramine treatment enhances the 7-OH-DPAT-induced hyperactivity in rats: the role of dopamine D2 and D3 receptors.
    Rogóz Z, Skuza G.
    Pol J Pharmacol; 2001 Sep 04; 53(6):571-6. PubMed ID: 11985330
    [Abstract] [Full Text] [Related]


    Page: [Previous] [Next] [New Search]
    of 8.